SEC Form 4 · accession 0001179110-15-012683
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel N Swisher Jr.
Officer — President and CEO · Director
Period of report
Aug 24, 2015
Accepted (ET)
Aug 26, 2015 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 24, 2015 | P | 12,784 | $1.01 | A | 187,520 | I | See footnote. |
| Common StockF2 | Aug 25, 2015 | P | 12,216 | $1.01 | A | 199,736 | I | See footnote. |
| Common Stock | holding | — | — | — | 179,510 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Because of a typographical error, the amount of securities beneficially owned indirectly by the reporting person was incorrectly reported as 174,336 shares instead of 174,736 shares in the last Form 4 filing. The total amount of the reporting person's indirect holdings on this report incorporates this correction.
- F2The shares are held by the Swisher Revocable Trust for which reporting person is a Trustee.